SMITS PHARMA LIMITEDActive

Company number 07217028Private limited companyIncorporated 2010

Key figures

£34-91.2%
Net assets 2025/26
-54.1%
Average annual change 2020/21–2025/26
02 k4 k6 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, SMITS PHARMA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 k10 k15 k2020/212021/222022/232023/242024/252025/26

Dividends

from the accounts
2022/23

Dividends paid in the financial year: £13,000.

History
2022/23£13,000
2021/22£0
2020/21£700
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand2,6241,6645,1809771,272
Total assets2,9153,23010,4114,9585,353
Total liabilities1,7102,9606,1844,5715,319
Net assets / total equity1,2052704,22738734
Average number of employees11111
Dividends paid013,000———

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: SMITS PHARMA LIMITED

Company

SMITS PHARMA LIMITED is a private limited company registered with Companies House under company number 07217028. It was incorporated on 8 Apr 2010. Its status is active. The registered office is in York (YO31). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Net assets were £34, down 91.2% on the previous year. Cash at bank and in hand was £1,272. Total assets were £5,353 and total liabilities £5,319. The company had an average of 1 employee. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 23 Mar 2027.